Bicara Therapeutics BCAX Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's common stock, par value (in dollars per share)?
- Bicara Therapeutics (BCAX) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Bicara Therapeutics's common stock, par value (in dollars per share) changed year-over-year?
- Bicara Therapeutics's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Bicara Therapeutics's common stock, par value (in dollars per share)?
- Over 2 years (2023 to 2025), Bicara Therapeutics's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.